Pursuant to the provisions of Regulation 30 (read with Part A of Schedule III) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), and in ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Integrated Proteins Limited, met on November 7, 2025, and approved the unaudited financial results for the quarter and half year ended September 30, 2025, along with the Limited Review Report by statutory auditors B.B. Gusani & Associates. Total revenue from operations for H1 FY26 stood at Rs 424.54 lakh, a sharp jump from just Rs 8.04 lakh in H1 FY25. The company swung to a profit before tax of Rs 6.73 lakh in H1 FY26 compared to a loss of Rs 3.52 lakh in H1 FY25, with net profit at Rs 5.04 lakh versus a loss of Rs 3.21 lakh earlier, taking basic EPS to Rs 0.16. Operating cash flow for H1 FY26 turned strongly positive at Rs 342.77 lakh versus a cash burn of Rs 14.91 lakh in H1 FY25, though reserves remain negative at Rs (29.39) lakh and short-term borrowings jumped sharply to Rs 389.55 lakh from Rs 9.27 lakh at March-end 2025. The company also confirmed that Rs 1,741.88 lakh raised through preferential issues has been used in line with the originally disclosed objects with no deviations.
This is a clear turnaround quarter for the company, with revenue and profits both swinging sharply higher year-on-year and strong operating cash flows, which is positive for shareholders. However, the still-negative reserves, a surge in short-term borrowings, and reliance on preferential fund raises (Rs 1,741.88 lakh) signal that the balance sheet remains weak and the business turnaround is still early-stage, warranting caution.